Oppenheimer maintains Medtronic (NYSE:MDT) $89 price target

By / / Medtronic, Oppenheimer

Oppenheimer analyst Steven Lichtman reiterates Medtronic (NYSE:MDT) with a Perform and maintains $89 price target.

Scroll to Top